14-3-3α and neuroglobin are new intrinsic protective factors for cerebral ischemia

Molecular Neurobiology

Volumn 41, Issue 2-3, 2010, Pages 218-231

  Dong, Yan ^a,b,c   Zhao, Rui ^a,b,c   Chen, Xiao Qian ^d   Yu, Albert Cheung Hoi ^a,b,c  

^a PEKING UNIVERSITY   (China)

^b Peking University   (China)

^c PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^d HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

14 3 3 ; Intrinsic protective protein; Neuroglobin; Preconditioning; Stroke

Indexed keywords

ACETYLSALICYLIC ACID; ALTEPLASE; ANTIOXIDANT; BASIC FIBROBLAST GROWTH FACTOR RECEPTOR; CALCIUM ANTAGONIST; CILIARY NEUROTROPHIC FACTOR; CLOPIDOGREL; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; DIPYRIDAMOLE; ERYTHROPOIETIN; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; GRANULOCYTE COLONY STIMULATING FACTOR; HEPARIN; HYPOXIA INDUCIBLE FACTOR 1; NERVE GROWTH FACTOR; NEUROGLOBIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PIGMENT EPITHELIUM DERIVED FACTOR; PROTEIN 14 3 3; PROTEIN 14 3 3 GAMMA; PROTEIN P53; STROMAL CELL DERIVED FACTOR 1; THROMBOCYTE ACTIVATING FACTOR; TICLOPIDINE; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR RECEPTOR 1; UNCLASSIFIED DRUG; UNINDEXED DRUG; VASCULOTROPIN; WARFARIN; GLOBIN; HYBRID PROTEIN; NERVE PROTEIN; NEUROPROTECTIVE AGENT;

APOPTOSIS; ASTROCYTE; BRAIN ISCHEMIA; CELL ORGANELLE; CONFERENCE PAPER; DRUG MECHANISM; FIBRINOLYTIC THERAPY; ISCHEMIC PRECONDITIONING; MITOCHONDRION; NEUROPROTECTION; NONHUMAN; PROTEIN EXPRESSION; TREATMENT INDICATION; UPREGULATION; ANIMAL; CLINICAL TRIAL; GENETICS; HUMAN; METABOLISM; NERVE CELL; PATHOLOGY; PATHOPHYSIOLOGY; REVIEW; STROKE;

14-3-3 PROTEINS; ANIMALS; ASTROCYTES; BRAIN ISCHEMIA; CLINICAL TRIALS AS TOPIC; GLOBINS; HUMANS; ISCHEMIC PRECONDITIONING; NERVE TISSUE PROTEINS; NEURONS; NEUROPROTECTIVE AGENTS; RECOMBINANT FUSION PROTEINS; STROKE;

EID: 77955089730     PISSN: 08937648     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12035-010-8142-4     Document Type: Conference Paper

References (128)

1. Fisher M, Takano K (1995) The penumbra, therapeutic time window and acute ischaemic stroke. Baillières Clin Neurol 4:279-295
2. Yao H, Okada Y, Ibayashi S (2002) Therapeutic time window for YAG laser-induced reperfusion of thrombotic stroke in hypertensive rats. NeuroReport 13:1005-1008
3. Kaplan B, Brint S, Tanabe J, Jacewicz M, Wang XJ, Pulsinelli W (1991) Temporal thresholds for neocortical infarction in rats subjected to reversible focal cerebral ischemia. Stroke 22:1032-1039
4. Memezawa H, Smith ML, Siesjo BK (1992) Penumbral tissues salvaged by reperfusion following middle cerebral artery occlusion in rats. Stroke 23:552-559
5. Baron JC, von Kummer R, del Zoppo GJ (1995) Treatment of acute ischemic stroke. Challenging the concept of a rigid and universal time window. Stroke 26:2219-2221
6. Murry CE, Jennings RB, Reimer KA (1986) Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 74:1124-1136
7. Shin JA, Park EM, Choi JS, Seo SM, Kang JL, Lee KE, Cho S (2009) Ischemic preconditioning-induced neuroprotection is associated with differential expression of IL-1beta and IL-1 receptor antagonist in the ischemic cortex. J Neuroimmunol 217:14-19
8. Kitagawa K, Matsumoto M, Tagaya M, Hata R, Ueda H, Niinobe M, Handa N, Fukunaga R, Kimura K, Mikoshiba K et al (1990) 'Ischemic tolerance' phenomenon found in the brain. Brain Res 528:21-24
9. Shao G, Gong KR, Li J, Xu XJ, Gao CY, Zeng XZ, Lu GW, Huo X (2009) Antihypoxic effects of neuroglobin in hypoxia-preconditioned mice and SH-SY5Y cells. Neurosignals 17:196-202
10. Murray CJ, Lopez AD (1997) Mortality by cause for eight regions of the world: Global Burden of Disease Study. Lancet 349:1269-1276
11. Hankey GJ, Jamrozik K, Broadhurst RJ, Forbes S, Burvill PW, Anderson CS, Stewart-Wynne EG (2000) Five-year survival after first-ever stroke and related prognostic factors in the Perth Community Stroke Study. Stroke 31:2080-2086
12. Liu M, Wu B, Wang WZ, Lee LM, Zhang SH, Kong LZ (2007) Stroke in China: epidemiology, prevention, and management strategies. Lancet Neurol 6:456-464
13. Hacke W, Kaste M, Fieschi C, Toni D, Lesaffre E, von Kummer R, Boysen G, Bluhmki E, Hoxter G, Mahagne MH et al (1995) Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS). JAMA 274:1017-1025
14. Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group (1995). N Engl J Med 333:1581-1587
15. Hacke W, Donnan G, Fieschi C, Kaste M, von Kummer R, Broderick JP, Brott T, Frankel M, Grotta JC, Haley EC Jr, Kwiatkowski T, Levine SR, Lewandowski C, Lu M, Lyden P, Marler JR, Patel S, Tilley BC, Albers G, Bluhmki E, Wilhelm M, Hamilton S (2004) Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet 363:768-774
16. CAST (Chinese Acute Stroke Trial) Collaborative Group (1997) CAST: randomised placebo-controlled trial of early aspirin use in 20, 000 patients with acute ischaemic stroke. Lancet 349:1641-1649
17. International Stroke Trial Collaborative Group (1997) The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischaemic stroke. Lancet 349:1569-1581
18. Gilligan AK, Thrift AG, Sturm JW, Dewey HM, Macdonell RA, Donnan GA (2005) Stroke units, tissue plasminogen activator, aspirin and neuroprotection: which stroke intervention could provide the greatest community benefit? Cerebrovasc Dis 20:239-244
19. Wahlgren N, Ahmed N, Davalos A, Hacke W, Millan M, Muir K, Roine RO, Toni D, Lees KR (2008) Thrombolysis with alteplase 3-4.5 h after acute ischaemic stroke (SITS-ISTR): an observational study. Lancet 372:1303-1309
20. Lyden P (2008) Thrombolytic therapy for acute stroke\not a moment to lose. N Engl J Med 359:1393-1395
21. Janoff A (1964) Alterations in lysosomes (intracellular enzymes) during shock; effects of preconditioning (tolerance) and protective drugs. Int Anesthesiol Clin 2:251-269
22. Bazan NG, Palacios-Pelaez R, Lukiw WJ (2002) Hypoxia signaling to genes: significance in Alzheimer's disease. Mol Neurobiol 26:283-298
23. Brown CM, Suzuki S, Jelks KA, Wise PM (2009) Estradiol is a potent protective, restorative, and trophic factor after brain injury. Semin Reprod Med 27:240-249
24. Chen XQ, Chen JG, Zhang Y, Hsiao WW, Yu AC (2003) 14-3-3gamma is upregulated by in vitro ischemia and binds to protein kinase Raf in primary cultures of astrocytes. Glia 42:315-324
25. Steiger HJ, Hanggi D (2007) Ischaemic preconditioning of the brain, mechanisms and applications. Acta Neurochir (Wien) 149:1-10
26. Kiessling M, Gass P (1993) Immediate early gene expression in experimental epilepsy. Brain Pathol 3:381-393
27. Nitta-Komatsubara Y, Abe K, Aoki M, Isoyama S (2000) Altered ischemic induction of immediate early gene and heat shock protein 70 mRNAs after preconditioning in rat hearts. Life Sci 66:1261-1270
28. Kawahara N, Wang Y, Mukasa A, Furuya K, Shimizu T, Hamakubo T, Aburatani H, Kodama T, Kirino T (2004) Genome-wide gene expression analysis for induced ischemic tolerance and delayed neuronal death following transient global ischemia in rats. J Cereb Blood Flow Metab 24:212-223
29. Tang Y, Pacary E, Freret T, Divoux D, Petit E, Schumann-Bard P, Bernaudin M (2006) Effect of hypoxic preconditioning on brain genomic response before and following ischemia in the adult mouse: identification of potential neuroprotective candidates for stroke. Neurobiol Dis 21:18-28
30. Liu HM, Li JX, Chen LB (2007) Ischemic preconditioning relieves ischemia/reperfusion injury of hippocampus neurons in rat by inhibiting p53 and bax expressions. Chin Med Sci J 22:123-127
31. Liu J, Narasimhan P, Yu F, Chan PH (2005) Neuroprotection by hypoxic preconditioning involves oxidative stress-mediated expression of hypoxia-inducible factor and erythropoietin. Stroke 36:1264-1269
32. Albers GW, Caplan LR, Easton JD, Fayad PB, Mohr JP, Saver JL, Sherman DG (2002) Transient ischemic attack\proposal for a new definition. N Engl J Med 347:1713-1716
33. Zsuga J, Gesztelyi R, Juhasz B, Kemeny-Beke A, Fekete I, Csiba L, Bereczki D (2008) Prior transient ischemic attack is independently associated with lesser in-hospital case fatality in acute stroke. Psychiatry Clin Neurosci 62:705-712
34. Schaller B (2005) Ischemic preconditioning as induction of ischemic tolerance after transient ischemic attacks in human brain: its clinical relevance. Neurosci Lett 377:206-211
35. Wegener S, Gottschalk B, Jovanovic V, Knab R, Fiebach JB, Schellinger PD, Kucinski T, Jungehulsing GJ, Brunecker P, Muller B, Banasik A, Amberger N, Wernecke KD, Siebler M, Rother J, Villringer A, Weih M (2004) Transient ischemic attacks before ischemic stroke: preconditioning the human brain? A multicenter magnetic resonance imaging study. Stroke 35:616-621
36. Botker HE, Kharbanda R, Schmidt MR, Bottcher M, Kaltoft AK, Terkelsen CJ, Munk K, Andersen NH, Hansen TM, Trautner S, Lassen JF, Christiansen EH, Krusell LR, Kristensen SD, Thuesen L, Nielsen SS, Rehling M, Sorensen HT, Redington AN, Nielsen TT (2006) Remote ischaemic conditioning before hospital admission, as a complement to angioplasty, and effect on myocardial salvage in patients with acute myocardial infarction: a randomised trial. Lancet 375:727-734
37. Does remote ischaemic preconditioning reduce heart and cerebral damage following carotid endarterectomy? A randomised controlled trial. [cited 2009 Feb 13]; Available from: http://www.controlled-trials.com/ISRCTN98544942
38. Treating patients with aneurysmal subarachnoid hemorrhage (SAH) with epoetin alfa (EPO). [cited 2009 Feb 13]; Available from: http://clinicaltrials. gov/ct2/show/NCT00626574
39. Birkle DL, Bazan NG (1987) Effect of bicuculline-induced status epilepticus on prostaglandins and hydroxyeicosatetraenoic acids in rat brain subcellular fractions. J Neurochem 48:1768-1778
40. Zhong B, Wang DH (2008) N-oleoyldopamine, a novel endogenous capsaicin-like lipid, protects the heart against ischemia-reperfusion injury via activation of TRPV1. Am J Physiol Heart Circ Physiol 295:H728-735
41. Rehni AK, Singh N, Jaggi AS (2007) Possible involvement of insulin, endogenous opioids and calcitonin gene-related peptide in remote ischaemic preconditioning of the brain. Yakugaku Zasshi 127:1013-1020
42. Traub ML, De Butte-Smith M, Suzanne Zukin R, Etgen AM (2009) Oestradiol and IGF1 reduce cell loss after global ischemia in middle-aged female rats. J Neuroendocrinol 21:1038-1044
43. Tixier E, Leconte C, Touzani O, Roussel S, Petit E, Bernaudin M (2008) Adrenomedullin protects neurons against oxygen glucose deprivation stress in an autocrine and paracrine manner. J Neurochem 106:1388-1403
44. Sayeed I, Stein DG (2009) Progesterone as a neuroprotective factor in traumatic and ischemic brain injury. Prog Brain Res 175:219-237
45. Matejovska I, Bernaskova K, Krysl D, Mares J (2008) Influence of melatonin pretreatment and preconditioning by hypobaric hypoxia on the development of cortical photothrombotic ische-mic lesion. Physiol Res 57:283-288
46. Doyle KP, Suchland KL, Ciesielski TM, Lessov NS, Grandy DK, Scanlan TS, Stenzel-Poore MP (2007) Novel thyroxine derivatives, thyronamine and 3-iodothyronamine, induce transient hypothermia and marked neuroprotection against stroke injury. Stroke 38:2569-2576
47. Rami A, Bechmann I, Stehle JH (2008) Exploiting endogenous anti-apoptotic proteins for novel therapeutic strategies in cerebral ischemia. Prog Neurobiol 85:273-296
48. Bazan NG (2005) Neuroprotectin D1 (NPD1): a DHA-derived mediator that protects brain and retina against cell injury-induced oxidative stress. Brain Pathol 15:159-166
49. Bazan NG (2007) Omega-3 fatty acids, pro-inflammatory signaling and neuroprotection. Curr Opin Clin Nutr Metab Care 10:136-141
50. Liu M, Eguchi N, Yamasaki Y, Urade Y, Hattori N, Urabe T (2009) Protective role of hematopoietic prostaglandin D synthase in transient focal cerebral ischemia in mice. Neuroscience 163:296-307
51. Liu Y, Chen L, Xu X, Vicaut E, Sercombe R (2009) Both ischemic preconditioning and ghrelin administration protect hippocampus from ischemia/reperfusion and upregulate uncoupling protein-2. BMC Physiol 9:17
52. Guo WP, Wang J, Li RX, Peng YW (2006) Neuroprotective effects of neuregulin-1 in rat models of focal cerebral ischemia. Brain Res 1087:180-185
53. Li X, Stark GR (2002) NFkappaB-dependent signaling pathways. Exp Hematol 30:285-296
54. Duckworth EA, Butler T, Collier L, Collier S, Pennypacker KR (2006) NF-kappaB protects neurons from ischemic injury after middle cerebral artery occlusion in mice. Brain Res 1088:167-175
55. Nijboer CH, Heijnen CJ, Groenendaal F, May MJ, van Bel F, Kavelaars A (2008) Strong neuroprotection by inhibition of NF-kappaB after neonatal hypoxia-ischemia involves apoptotic mechanisms but is independent of cytokines. Stroke 39:2129-2137
56. Nijboer CH, Heijnen CJ, Groenendaal F, May MJ, van Bel F, Kavelaars A (2008) A dual role of the NF-kappaB pathway in neonatal hypoxic-ischemic brain damage. Stroke 39:2578-2586
57. Blondeau N, Widmann C, Lazdunski M, Heurteaux C (2001) Activation of the nuclear factor-kappaB is a key event in brain tolerance. J Neurosci 21:4668-4677
58. Ran R, Xu H, Lu A, Bernaudin M, Sharp FR (2005) Hypoxia preconditioning in the brain. Dev Neurosci 27:87-92
59. O'Rourke JF, Dachs GU, Gleadle JM, Maxwell PH, Pugh CW, Stratford IJ, Wood SM, Ratcliffe PJ (1997) Hypoxia response elements. Oncol Res 9:327-332
60. Sharp FR, Ran R, Lu A, Tang Y, Strauss KI, Glass T, Ardizzone T, Bernaudin M (2004) Hypoxic preconditioning protects against ischemic brain injury. NeuroRx 1:26-35
61. Liu R, Suzuki A, Guo Z, Mizuno Y, Urabe T (2006) Intrinsic and extrinsic erythropoietin enhances neuroprotection against ischemia and reperfusion injury in vitro. J Neurochem 96:1101-1110
62. Grimm C, Wenzel A, Acar N, Keller S, Seeliger M, Gassmann M (2006) Hypoxic preconditioning and erythropoietin protect retinal neurons from degeneration. Adv Exp Med Biol 588:119-131
63. Du Y, Li C, Hu WW, Song YJ, Zhang GY (2009) Neuro-protection of preconditioning against ischemic brain injury in rat hippocampus through inhibition of the assembly of GluR6-PSD95-mixed lineage kinase 3 signaling module via nuclear and non-nuclear pathways. Neuroscience 161:370-380
64. Chen XQ, Qin LY, Zhang CG, Yang LT, Gao Z, Liu S, Lau LT, Fung YW, Greenberg DA, Yu AC (2005) Presence of neuro-globin in cultured astrocytes. Glia 50:182-186
65. Chen XQ, Yu AC (2002) The association of 14-3-3gamma and actin plays a role in cell division and apoptosis in astrocytes. Biochem Biophys Res Commun 296:657-663
66. Moore BW, Perez VJ (1967) Specific acid proteins in nervous system. In: Carlson FD (ed) Physiological and biochemical aspects of nervous intergration. Prentice-Hall, Englewood Cliffs, pp 343-359
67. Fu H, Subramanian RR, Masters SC (2000) 14-3-3 proteins: structure, function, and regulation. Annu Rev Pharmacol Toxicol 40:617-647
68. Masters SC, Fu H (2001) 14-3-3 proteins mediate an essential anti-apoptotic signal. J Biol Chem 276:45193-45200
69. Pirim I (1998) Ischemic rat brains contain immunoreactivity of 14-3-3 proteins. Int J Neurosci 95:101-106
70. Jang SW, Liu X, Fu H, Rees H, Yepes M, Levey A, Ye K (2009) Interaction of Akt-phosphorylated SRPK2 with 14-3-3 mediates cell cycle and cell death in neurons. J Biol Chem 284:24512-24525
71. Chen XQ, Fung YW, Yu AC (2005) Association of 14-3-3gamma and phosphorylated bad attenuates injury in ischemic astrocytes. J Cereb Blood Flow Metab 25:338-347
72. Dong Y, Liu HD, Zhao R, Yang CZ, Chen XQ, Wang XH, Lau LT, Chen J, Yu AC (2009) Ischemia activates JNK/c-Jun/AP-1 pathway to up-regulate 14-3-3gamma in astrocyte. J Neurochem 109(Suppl 1):182-188
73. Yu AC, Wong HK, Yung HW, Lau LT (2001) Ischemia-induced apoptosis in primary cultures of astrocytes. Glia 35:121-130
74. Zha J, Harada H, Yang E, Jockel J, Korsmeyer SJ (1996) Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3 not BCL-X(L). Cell 87:619-628
75. Wang HG, Pathan N, Ethell IM, Krajewski S, Yamaguchi Y, Shibasaki F, McKeon F, Bobo T, Franke TF, Reed JC (1999) Ca2+-induced apoptosis through calcineurin dephosphorylation of BAD. Science 284:339-343
76. Su QJ, Chen XW, Chen ZB, Sun SG (2008) Involvement of ERK1/2 and p38 MAPK in up-regulation of 14-3-3 protein induced by hydrogen peroxide preconditioning in PC12 cells. Neurosci Bull 24:244-250
77. Kawamoto Y, Akiguchi I, Tomimoto H, Shirakashi Y, Honjo Y, Budka H (2006) Upregulated expression of 14-3-3 proteins in astrocytes from human cerebrovascular ischemic lesions. Stroke 37:830-835
78. Fujii K, Tanabe Y, Kobayashi K, Uchikawa H, Kohno Y (2005) Detection of 14-3-3 protein in the cerebrospinal fluid in mitochondrial encephalopathy with lactic acidosis and strokelike episodes. J Neurol Sci 239:115-118
79. Siman R, McIntosh TK, Soltesz KM, Chen Z, Neumar RW, Roberts VL (2004) Proteins released from degenerating neurons are surrogate markers for acute brain damage. Neurobiol Dis 16:311-320
80. Umahara T, Uchihara T, Tsuchiya K, Nakamura A, Iwamoto T (2007) Intranuclear localization and isoform-dependent translo-cation of 14-3-3 proteins in human brain with infarction. J Neurol Sci 260:159-166
81. Satoh J, Tabunoki H, Nanri Y, Arima K, Yamamura T (2006) Human astrocytes express 14-3-3 sigma in response to oxidative and DNA-damaging stresses. Neurosci Res 56:61-72
82. Chen XQ, Liu S, Qin LY, Wang CR, Fung YW, Yu AC (2005) Selective regulation of 14-3-3eta in primary culture of cerebral cortical neurons and astrocytes during development. J Neurosci Res 79:114-118
83. Wu JS, Cheung WM, Tsai YS, Chen YT, Fong WH, Tsai HD, Chen YC, Liou JY, Shyue SK, Chen JJ, Chen YE, Maeda N, Wu KK, Lin TN (2009) Ligand-activated peroxisome proliferator-activated receptor-gamma protects against ischemic cerebral infarction and neuronal apoptosis by 14-3-3 epsilon upregula-tion. Circulation 119:1124-1134
84. Yang C, Ren Y, Liu F, Cai W, Zhang N, Nagel DJ, Yin G (2008) Ischemic preconditioning suppresses apoptosis of rabbit spinal neurocytes by inhibiting ASK1-14-3-3 dissociation. Neurosci Lett 441:267-271
85. Chen HP, He M, Xu YL, Huang QR, Zeng GH, Liu D, Liao ZP (2007) Anoxic preconditioning up-regulates 14-3-3 protein expression in neonatal rat cardiomyocytes through extracellular signal-regulated protein kinase 1/2. Life Sci 81:372-379
86. Burmester T, Weich B, Reinhardt S, Hankeln T (2000) A vertebrate globin expressed in the brain. Nature 407:520-523
87. Merx MW, Flogel U, Stumpe T, Godecke A, Decking UK, Schrader J (2001) Myoglobin facilitates oxygen diffusion. FASEB J 15:1077-1079
88. Kriegl JM, Bhattacharyya AJ, Nienhaus K, Deng P, Minkow O, Nienhaus GU (2002) Ligand binding and protein dynamics in neuroglobin. Proc Natl Acad Sci USA 99:7992-7997
89. Sun Y, Jin K, Peel A, Mao XO, Xie L, Greenberg DA (2003) Neuroglobin protects the brain from experimental stroke in vivo. Proc Natl Acad Sci USA 100:3497-3500
90. Khan AA, Wang Y, Sun Y, Mao XO, Xie L, Miles E, Graboski J, Chen S, Ellerby LM, Jin K, Greenberg DA (2006) Neuroglobin-overexpressing transgenic mice are resistant to cerebral and myocardial ischemia. Proc Natl Acad Sci USA 103:17944-17948
91. Jin K, Mao Y, Mao X, Xie L, Greenberg DA (2010) Neuroglobin expression in ischemic stroke. Stroke 41:557-559
92. Gabriel C, Ali C, Lesne S, Fernandez-Monreal M, Docagne F, Plawinski L, MacKenzie ET, Buisson A, Vivien D (2003) Transforming growth factor alpha-induced expression of type 1 plasminogen activator inhibitor in astrocytes rescues neurons from excitotoxicity. FASEB J 17:277-279
93. Yang LT, Gao Z, Li HL, Lu J, Yu AC (2007) Neuroglobin but not cytoglobin binds specifically to mitochondria in neural cells. In the 7th Biennial Meeting and the 5th Congress of the Chinese Society for Neuroscience of Conference. Hangzhou, China: Springer Verlag. 23:387-388
94. Flogel U, Merx MW, Godecke A, Decking UK, Schrader J (2001) Myoglobin: a scavenger of bioactive NO. Proc Natl Acad Sci USA 98:735-740
95. Ligon LA, Steward O (2000) Movement of mitochondria in the axons and dendrites of cultured hippocampal neurons. J Comp Neurol 427:340-350
96. Ye SQ, Zhou XY, Lai XJ, Zheng L, Chen XQ (2009) Silencing neuroglobin enhances neuronal vulnerability to oxidative injury by down-regulating 14-3-3gamma. Acta Pharmacol Sin 30:913-918
97. Sevimli S, Diederich K, Strecker JK, Schilling M, Klocke R, Nikol S, Kirsch F, Schneider A, Schabitz WR (2009) Endogenous brain protection by granulocyte-colony stimulating factor after ischemic stroke. Exp Neurol 217:328-335
98. Ma YP, Ma MM, Cheng SM, Ma HH, Yi XM, Xu GL, Liu XF (2008) Intranasal bFGF-induced progenitor cell proliferation and neuroprotection after transient focal cerebral ischemia. Neurosci Lett 437:93-97
99. Roitbak T, Li L, Cunningham LA (2008) Neural stem/progenitor cells promote endothelial cell morphogenesis and protect endothelial cells against ischemia via HIF-1alpha-regulated VEGF signaling. J Cereb Blood Flow Metab 28:1530-1542
100. Chang YC, Shyu WC, Lin SZ, Li H (2007) Regenerative therapy for stroke. Cell Transplant 16:171-181
101. Siliprandi R, Canella R, Carmignoto G (1993) Nerve growth factor promotes functional recovery of retinal ganglion cells after ischemia. Invest Ophthalmol Vis Sci 34:3232-3245
102. Yoo JY, Won YJ, Lee JH, Kim JU, Sung IY, Hwang SJ, Kim MJ, Hong HN (2009) Neuroprotective effects of erythropoietin posttreatment against kainate-induced excitotoxicity in mixed spinal cultures. J Neurosci Res 87:150-163
103. Weber AJ, Harman CD, Viswanathan S (2008) Effects of optic nerve injury, glaucoma, and neuroprotection on the survival, structure, and function of ganglion cells in the mammalian retina. J Physiol 586:4393-4400
104. Marciniak K, Butwicka A, Nowak JZ (2006) PEDF: an endogenous factor displaying potent neuroprotective, neuro-trophic, and antiangiogenic activity. Postepy Hig Med Dosw (Online) 60:387-396
105. Parrilla-Reverter G, Agudo M, Sobrado-Calvo P, Salinas-Navarro M, Villegas-Perez MP, Vidal-Sanz M (2009) Effects of different neurotrophic factors on the survival of retinal ganglion cells after a complete intraorbital nerve crush injury: a quantitative in vivo study. Exp Eye Res 89:32-41
106. Li J, Qu Y, Li X, Li D, Zhao F, Mao M, Ferriero D, Mu D (2010) The role of integrin alpha(v)beta (8) in neonatal hypoxic-ischemic brain injury. Neurotox Res 17:406-417
107. Lin CH, Cheng FC, Lu YZ, Chu LF, Wang CH, Hsueh CM (2006) Protection of ischemic brain cells is dependent on astrocyte-derived growth factors and their receptors. Exp Neurol 201:225-233
108. Meucci O, Fatatis A, Simen AA, Miller RJ (2000) Expression of CX3CR1 chemokine receptors on neurons and their role in neuronal survival. Proc Natl Acad Sci USA 97:8075-8080
109. Whitlock NA, Agarwal N, Ma JX, Crosson CE (2005) Hsp27 upregulation by HIF-1 signaling offers protection against retinal ischemia in rats. Invest Ophthalmol Vis Sci 46:1092-1098
110. Yi JH, Park SW, Kapadia R, Vemuganti R (2007) Role of transcription factors in mediating post-ischemic cerebral inflammation and brain damage. Neurochem Int 50:1014-1027
111. Rybnikova E, Glushchenko T, Tyulkova E, Baranova K, Samoilov M (2009) Mild hypobaric hypoxia preconditioning up-regulates expression of transcription factors c-Fos and NGFI-A in rat neocortex and hippocampus. Neurosci Res 65:360-366
112. Ouk T, Laprais M, Bastide M, Mostafa K, Gautier S, Bordet R (2009) Withdrawal of fenofibrate treatment partially abrogates preventive neuroprotection in stroke via loss of vascular protection. Vascul Pharmacol 51:323-330
113. Zhao X, Strong R, Zhang J, Sun G, Tsien JZ, Cui Z, Grotta JC, Aronowski J (2009) Neuronal PPARgamma deficiency increases susceptibility to brain damage after cerebral ischemia. J Neurosci 29:6186-6195
114. Fan X, Heijnen CJ, van der Kooij MA, Groenendaal F, van Bel F (2009) The role and regulation of hypoxia-inducible factor-1alpha expression in brain development and neonatal hypoxic-ischemic brain injury. Brain Res Rev 62:99-108
115. Chan PH (1994) Oxygen radicals in focal cerebral ischemia. Brain Pathol 4:59-65
116. Desagher S, Glowinski J, Premont J (1996) Astrocytes protect neurons from hydrogen peroxide toxicity. J Neurosci 16:2553-2562
117. Kelley MH, Taguchi N, Ardeshiri A, Kuroiwa M, Hurn PD, Traystman RJ, Herson PS (2008) Ischemic insult to cerebellar Purkinje cells causes diminished GABAA receptor function and allopregnanolone neuroprotection is associated with GABAA receptor stabilization. J Neurochem 107:668-678
118. Solaroglu I, Jadhav V, Zhang JH (2007) Neuroprotective effect of granulocyte-colony stimulating factor. Front Biosci 12:712-724
119. Sadasivan S, Maher TJ, Quang LS (2006) Gamma-Hydroxybutyrate (GHB), gamma-butyrolactone (GBL), and 1, 4-butanediol (1, 4-BD) reduce the volume of cerebral infarction in rodent transient middle cerebral artery occlusion. Ann N Y Acad Sci 1074:537-544
120. Salazar-Colocho P, Del Rio J, Frechilla D (2008) Neuro-protective effects of serotonin 5-HT 1A receptor activation against ischemic cell damage in gerbil hippocampus: involvement of NMDA receptor NR1 subunit and BDNF. Brain Res 1199:159-166
121. Molina-Holgado F, Pinteaux E, Moore JD, Molina-Holgado E, Guaza C, Gibson RM, Rothwell NJ (2003) Endogenous interleukin-1 receptor antagonist mediates anti-inflammatory and neuroprotective actions of cannabinoids in neurons and glia. J Neurosci 23:6470-6474
122. Pinteaux E, Rothwell NJ, Boutin H (2006) Neuroprotective actions of endogenous interleukin-1 receptor antagonist (IL-1ra) are mediated by glia. Glia 53:551-556
123. Li RC, Morris MW, Lee SK, Pouranfar F, Wang Y, Gozal D (2008) Neuroglobin protects PC12 cells against oxidative stress. Brain Res 1190:159-166
124. Sinor AD, Irvin SM, Greenberg DA (2000) Endocannabinoids protect cerebral cortical neurons from in vitro ischemia in rats. Neurosci Lett 278:157-160
125. Sweeney MI (1997) Neuroprotective effects of adenosine in cerebral ischemia: window of opportunity. Neurosci Biobehav Rev 21:207-217
126. Ouyang YB, Giffard RG (2004) Cellular neuroprotective mechanisms in cerebral ischemia: Bcl-2 family proteins and protection of mitochondrial function. Cell Calcium 36:303-311
127. Franklin TB, Krueger-Naug AM, Clarke DB, Arrigo AP, Currie RW (2005) The role of heat shock proteins Hsp70 and Hsp27 in
128. Andine P, Lehmann A, Ellren K, Wennberg E, Kjellmer I, Nielsen T, Hagberg H (1988) The excitatory amino acid antagonist kynurenic acid administered after hypoxic-ischemia in neonatal rats offers neuroprotection. Neurosci Lett 90:208-212